Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.
about
Gene therapy for carcinoma of the breast: Genetic immunotherapyRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsThe present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene productImmunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell responseClinical implications of the new biology in the development of melanoma vaccines.Tumor Therapy Applying Membrane-bound Form of Cytokines.Gene transfer of Fas ligand induces tumor regression in vivo.Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.Lymphokines post autologous peripheral blood stem cell transplantation in children.Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.Local expression of antiinflammatory cytokines in cancerImmunomodulation of cancer: potential use of selectively replicating agents.Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer modelHuman tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID miceVirotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors.Innovations and strategies for the development of anticancer vaccines.Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Cancer vaccines: the interleukin 2 dosage effectInterleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanismGene therapy for paediatric leukaemia.Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.Combination gene therapy for liver metastasis of colon carcinoma in vivoIn vivo cytokine gene transfer by gene gun reduces tumor growth in miceSpontaneous regression of neoplasms: new possibilities for immunotherapy.CD4+ T cell matters in tumor immunity.Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantImmunotherapy with sensitized lymphocytes.Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes.IL2 treatment for cancer: from biology to gene therapyPersistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protectionImmunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.Antigen-presenting cell engineering. The molecular toolboxConcepts and strategies for human gene therapy.Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.Gene transfer approaches in cancer immunotherapy.
P2860
Q24797848-723F850E-64A0-403D-9948-D6268E65EEABQ26779221-53715C77-AAEC-425D-A4DC-C2D52EBFBE3AQ30425111-24BE6A71-8C19-4274-8664-AE339D4A4D27Q30453892-08276A2B-EA32-4ADF-926D-B21EF5D9094DQ31155155-37A5C1EF-05EC-4104-869F-8B9693DC1097Q33603062-59407416-3D28-41F1-834A-DF8EE3B98682Q33631960-E81ABEF4-DDE6-4C24-9827-C685C975D7CBQ33731661-DFFBEBAC-4187-4D3C-BB4A-BE40BC1C8AEAQ33778847-2CB7EFBF-55AD-4A8F-8F62-26B7C98DC3BEQ33847106-D8925F72-1057-4219-9EAA-4109F3CEC5E6Q33854375-6DA18B5A-CBF1-409E-9DF0-3ECD79E99562Q33893313-51BEB8EA-71FE-46FC-A982-46B33FE779C3Q33904276-A9109C93-3E1B-4EBC-8E47-128ECC10826FQ33989165-08DF31B2-AAFC-4B2C-892E-47E47CEE4529Q34035529-F592C902-21EA-4E44-8145-3D9283D24894Q34110762-A4047DC7-08CB-407D-8211-6AEFAD52A61AQ34141837-23A8F6D0-B8D7-495E-939B-CC3A103E32DAQ34169782-5F41DB5C-9C87-4AFC-9D48-685347FB7BEAQ34182039-8C5B521F-907C-4DDD-8FDA-E94B581A622DQ34235329-805B00E5-5EB4-46AD-A444-DD59ADB6D15EQ34334817-DEE5451F-38E4-49F9-961C-5A35829CCF8AQ34361454-0E2AF4CD-D1E3-4833-8DB1-2594F14B857AQ34392868-33F7C4E8-0FD3-4A4F-935F-9B68BB9AE065Q34451905-2F8DA9C8-E202-48CA-969A-A078FF788DEBQ34452039-9F8883AC-F875-43E1-940E-D178C38B15D6Q34480736-9ED434F4-B6CF-4058-A40D-635DA2A0392CQ34513704-E413E8B0-51E2-406C-81A7-30D8C10D60CDQ34701352-24CCB622-6226-455D-B40D-3BB73190B80DQ35214403-5EC82EB9-A3A1-4C8F-B63E-3222D57E8A49Q35319290-77D22518-B133-4021-80E9-1CF1D7E9C225Q35367163-D14F5272-6196-4465-A7E6-75E7F8D99A7CQ35454954-639B59C5-C4DF-480F-A855-0197116C1DE5Q35565971-AF7B5F24-7177-42AA-85DC-7A1AD70126E9Q35636865-F8179857-CD72-425C-BA1F-C775ED086E5CQ35670636-66547E80-64D3-4841-A192-83AC1E3054E8Q35755567-F0A4D0E2-2C96-4EE1-BBC0-ADE76825A978Q35773889-1B476D69-0BFF-49FD-83A2-76576D1B6B3FQ35816188-31E909D5-A109-4D66-A50B-485D916F3AF9Q35848688-6B35B465-1A0F-46CC-846E-5E40238C6D4DQ35904413-CD681007-34DE-4E01-8F0D-BA2F20A51647
P2860
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Interleukin-2 production by tu ...... tion of an antitumor response.
@en
type
label
Interleukin-2 production by tu ...... tion of an antitumor response.
@en
prefLabel
Interleukin-2 production by tu ...... tion of an antitumor response.
@en
P2093
P1433
P1476
Interleukin-2 production by tu ...... tion of an antitumor response.
@en
P2093
Golumbek P
Karasuyama H
Levitsky HI
Pardoll DM
P304
P356
10.1016/0092-8674(90)90591-2
P407
P577
1990-02-01T00:00:00Z